South African tycoon Gus Attridge’s Aspen stake rebounds above $100 million
South African businessman Gus Attridge’s stake in Aspen Pharmacare rebounds above $100 million as the company’s shares recover on the JSE.
Skip to content
South African businessman Gus Attridge’s stake in Aspen Pharmacare rebounds above $100 million as the company’s shares recover on the JSE.
Aspen co-founder Gus Attridge loses $15.8 million in three weeks as drug stocks fall, cutting Aspen’s value below $2.6 billion.
Gus Attridge’s Aspen Pharmacare stake drops over $12 million as shares slide 9.45%, pushing market value below $3 billion.
Shares of Aspen Pharmacare plunged 5.44 percent in a week, wiping millions off co-founder Gus Attridge’s stake.
This follows a strong recovery in Aspen's share price on the Johannesburg Stock Exchange (JSE).
Attridge, co-founder and group chief advisor of Aspen Pharmacare, holds a 4.3-percent stake in the company.
His 19,188,850 shares are now valued at R3.24 billion ($175.82 million), reflecting the latest decline in Aspen’s stock price.
This corresponds to a 5.24 percent drop in Aspen’s stock price on the Johannesburg Stock Exchange (JSE) in 9 days.
This corresponds to an 18.12 percent drop in Aspen’s stock price on the Johannesburg Stock Exchange (JSE) since the start of the year.
South African pharma mogul Gus Attridge loses $16.5 million from stake in Africa’s largest pharmaceutical company.
Attridge, who serves as the group’s chief advisor, holds a 4.3-percent stake in the Durban-based pharmaceutical giant, amounting to 19,033,829 shares.
This follows a $12 million gain recorded between April 23 and May 3, when his stake rose from R4.07 billion ($219.65 million) to R4.29 billion ($231.65 million).
Attridge, Aspen’s group chief advisor, and a JSE heavyweight, holds a 4.3-percent stake in the pharmaceutical company, amounting to 19,033,829 ordinary shares.
The latest bump in his fortune comes on the heels of previous gains between Feb. 12 and March 24, when his stake in Aspen grew by R447.12 million ($25.12 million).